Baxter is a global healthcare company with a leading portfolio of critical care, nutrition, renal, hospital and surgical products and we are driven by our mission to save and sustain lives. We stand ready to partner with EU policy-makers during the on-going process to modernise the EU’s regulatory environment for pharmaceuticals.
BAX
Baxter
Company · United States · EU Transparency Register 84050217165-45
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1048 companies & groups on this site, they rank #472 by legislative files engaged — a count of participation, not a measure of influence.
0.2
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2011
in the register since
Declares membership of
- MedTech Europe →
- MNI (Medical Nutrition Industry)
- Medicines for Europe →
- Europen
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Companies & groups
- Head office
- Zurich, Switzerland
- EU office
- Braine l'Alleud
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Baxter in PolicySpeak: request access →
Work at Baxter? so we know who speaks for it.
Their record over time
Baxter filed 2 positions between 27 Apr 2021 and 28 Jun 2022, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
2021 · 1 filed2022 · 1 filed
What they argued
Baxter is a leading global pharmaceutical & medical device company committed to delivering life-saving and sustaining products. We have been working with clinicians and hospitals across Europe for years to provide anaesthetic agents (inhaled & intravenous) that allow clinical treatment to be tailored to specific patient needs.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Baxter next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 8.
Is this your organization?
Everything on this page comes from Baxter’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.